Sriram Ravichandran

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Primary plasma cell leukaemia in a young transplant eligible patient brings forth a number of perplexing questions and many remain unanswered. There are good data to suggest the superiority of novel agents over conventional chemotherapy regimens, however choosing between autologous and allogeneic haematopoietic stem cell transplant in first remission(More)
  • 1